Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001209191-18-050362

Chief Medical Officer acquired 142,857 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Londei Marco · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-09-07 Exercise or conversion : show line 1 in the form +142,857 $0.70 $100,000 144,877 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-09-07 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −142,857 $0.70 2024-10-27 142,857 18,108 D
Loading xslF345X03/doc4.xml…